Vital Chemtech is a pure-play phosphorus chemist - it takes elemental phosphorus and transforms it into six specialist derivatives that other manufacturers cannot make without. Born from a family trading business in 1993 and reshaped through a series of restructurings into a public company listed on the NSE Main Board, the firm has spent a decade refining a single, repeatable formula: pick a phosphorus molecule with wide industrial demand, master its production at an automated plant in Gujarat’s chemical corridor, and sell it to a diversified base of pharma, agrochemical and specialty-chemical customers, never letting any one buyer dominate the order book. # Business segments A single integrated engine - phosphorus derivative manufacturing, supplemented by raw-material trading - that supplies six molecules to pharma, agrochemical and industrial customers, with two subsidiaries extending the chemistry into alkoxides and custom synthesis. ## 1. Phosphorus derivatives: the group’s chemical factory **One integrated plant makes six phosphorus-based intermediates, sold on purchase order to over five end-markets, with no customer accounting for more than a tenth of revenue.** - **Six molecules, one site** - the Dahej complex produces Phosphorus Trichloride, Phosphorus Oxychloride, Phosphorus Pentachloride, Phosphorus Pentoxide, Poly Phosphoric Acid and Phosphorus Pentasulfide under one roof, giving the company a cumulative capacity of 28,800 tonnes after a 2022 expansion more than doubled its earlier scale. - **Pharma is the biggest pull** - every product in the portfolio feeds into active pharmaceutical ingredients or their intermediates, from Pantoprazole and Losartan to oncology, antipsychotic and antibiotic drugs, so the company’s fortunes are tied to the health of the generic-medicine supply chain. - **Agrochemicals and EVs provide the next layer** - the same molecules are essential for technical-grade pesticides and organophosphate textile auxiliaries, while Phosphorus Pentachloride is an emerging input for lithium-ion battery electrolyte, giving the portfolio a foothold in electrification without a separate business line. - **BIS licences act as quality gates** - the company holds Bureau of Indian Standards certifications for its Phosphorus Trichloride, Phosphorus Pentachloride and Poly Phosphoric Acid, and claims to be the first to secure the BIS licence for Phosphorus Pentachloride, Technical, which signals product purity to exacting industrial buyers. - **Trading fills the gaps** - alongside its own production, the company trades its raw material, which appears as a secondary reporting segment and likely helps it manage input costs or serve customers who need material outside its own manufacturing slate. # Group structure and partners **Two majority-owned subsidiaries extend the chemistry into alkoxides and custom synthesis, with one already contributing and the other poised to start commercial production.** - **Vital Alkoxides - the operating subsidiary** - 70%-owned, it makes sodium methoxide in solution and powder form for pharmaceuticals, biodiesel and fine chemicals, turned EBITDA-positive in its first full year and holds a consolidated environmental consent. - **Vital Synthesis - the near-term growth leg** - 99%-owned, it received its final operating consent in June 2026 to manufacture a wide slate of pesticide intermediates, pharmaceutical intermediates, specialty phenols and chlorinated compounds at a new Dahej plant, with commercial production expected within the current financial year. - **The family remains at the centre** - the Chairman and Managing Director, his spouse and his son hold the key executive roles, while a cluster of associate concerns spans chemicals, wellness, packaging and dye intermediates, creating a network of related-party entities around the listed company.